MBX2329 is a small-molecule inhibitor that specifically blocks hemagglutinin (HA)-mediated viral entry. It demonstrates inhibitory activity against influenza strains including H1N1 and highly pathogenic H5N1, making it a useful tool for studying viral entry mechanisms in both in vitro and in vivo research models.